Michael Burkes Brophy, the CHIEF FINANCIAL OFFICER of $NTRA ($NTRA), sold 259 shares of the company on 01-24-2025 for an estimated $44,662. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.2% of their shares of this class of stock. Following this trade, they now own 109,474 shares of this class of $NTRA stock.
$NTRA Insider Trading Activity
$NTRA insiders have traded $NTRA stock on the open market 146 times in the past 6 months. Of those trades, 0 have been purchases and 146 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
- MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) has made 0 purchases and 11 sales selling 164,000 shares for an estimated $27,184,125.
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has made 0 purchases and 20 sales selling 109,057 shares for an estimated $16,751,366.
- ROELOF BOTHA has made 0 purchases and 5 sales selling 87,473 shares for an estimated $14,793,563.
- JONATHAN SHEENA has made 0 purchases and 54 sales selling 96,771 shares for an estimated $13,672,356.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 15 sales selling 37,497 shares for an estimated $5,689,049.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has made 0 purchases and 10 sales selling 35,089 shares for an estimated $5,628,578.
- ROY D. BAYNES has made 0 purchases and 6 sales selling 37,230 shares for an estimated $5,439,564.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has made 0 purchases and 7 sales selling 31,192 shares for an estimated $5,058,455.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has made 0 purchases and 9 sales selling 28,252 shares for an estimated $4,340,704.
- GAIL BOXER MARCUS has made 0 purchases and 7 sales selling 11,894 shares for an estimated $1,899,602.
- ROWAN E CHAPMAN has made 0 purchases and 2 sales selling 4,381 shares for an estimated $634,563.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NTRA Hedge Fund Activity
We have seen 250 institutional investors add shares of $NTRA stock to their portfolio, and 245 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,341,756 shares (+442.8%) to their portfolio in Q3 2024, for an estimated $297,285,924
- WELLINGTON MANAGEMENT GROUP LLP added 1,883,481 shares (+205.4%) to their portfolio in Q3 2024, for an estimated $239,107,912
- DUQUESNE FAMILY OFFICE LLC added 1,591,970 shares (+80.6%) to their portfolio in Q3 2024, for an estimated $202,100,591
- BLACKROCK, INC. added 1,461,550 shares (+21.6%) to their portfolio in Q3 2024, for an estimated $185,543,772
- JPMORGAN CHASE & CO removed 1,433,790 shares (-23.6%) from their portfolio in Q3 2024, for an estimated $182,019,640
- FRED ALGER MANAGEMENT, LLC removed 1,250,664 shares (-23.8%) from their portfolio in Q3 2024, for an estimated $158,771,794
- AMERIPRISE FINANCIAL INC removed 861,463 shares (-26.0%) from their portfolio in Q3 2024, for an estimated $109,362,727
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NTRA Congressional Stock Trading
Members of Congress have traded $NTRA stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 11/20.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.